Vir Biotechnology, Inc. VIR Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s operating lease liabilities (current)?
- Vir Biotechnology, Inc. (VIR) reported operating lease liabilities (current) of $8.94M in Q1 2026.
- How has Vir Biotechnology, Inc.'s operating lease liabilities (current) changed year-over-year?
- Vir Biotechnology, Inc.'s operating lease liabilities (current) increased by 12.9% year-over-year, from $7.93M to $8.94M.
- What is the long-term trend for Vir Biotechnology, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s operating lease liabilities (current) has grown at a 19.4% compound annual growth rate (CAGR), from $3.63M to $8.8M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.